Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M

Akers Biosciences reports 2021 executive compensation

By ExecPay News

Published: October 26, 2022

Akers Biosciences reported fiscal year 2021 executive compensation information on October 26, 2022.
In 2021, four executives at Akers Biosciences received on average a compensation package of $3.4M, a 690% increase compared to previous year.
Average pay of disclosed executives at Akers Biosciences
Adam Kaplin, Chief Scientific Officer, received $5.2M in total, which increased by 1,350% compared to 2020. 93% of Kaplin's compensation, or $4.9M, was in stock awards. Kaplin also received $127K in bonus and $250K in salary.
Christopher Chapman, Chief Medical Officer, received a compensation package of $5.1M, which increased by 1628% compared to previous year. 94% of the compensation package, or $4.9M, was in stock awards.
Paul Rivard, General Counsel, earned $1.8M in 2021, a 953% increase compared to previous year.
Christopher C. Schreiber, Chief Executive Officer, received $1.5M in 2021, which increases by 38% compared to 2020.

Related executives

Christopher Chapman

Akers Biosciences

Chief Medical Officer

Adam Kaplin

Akers Biosciences

Chief Scientific Officer

Christopher Schreiber

Akers Biosciences

Chief Executive Officer

Paul Rivard

Akers Biosciences

Chief Legal Officer

You may also like

Source: SEC filing on October 26, 2022.